A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
NCT00002123 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate the safety, tolerance, pharmacokinetics, and efficacy of delavirdine mesylate (U-90152S) in combination with didanosine (ddI) versus ddI alone in HIV-positive patients.
Conditions
- HIV Infections
Interventions
- DRUG
-
Delavirdine mesylate
- DRUG
-
Didanosine
Sponsors & Collaborators
-
Pharmacia and Upjohn
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002401 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
NCT00002224 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
NCT00000919 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
NCT00007202 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
NCT00001063 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002400 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 ·Status: COMPLETED ·Phase: NA
-
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
NCT00000851 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
NCT00002176 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002234 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Efavirenz in Combination With Stavudine and Didanosine
NCT00002225 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002418 ·Status: TERMINATED ·Phase: PHASE2
-
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
NCT00000882 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
NCT00002236 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002411 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
NCT00002213 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs
NCT00300573 ·Status: TERMINATED ·Phase: PHASE2
-
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 ·Status: COMPLETED ·Phase: NA
-
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
NCT00002177 ·Status: COMPLETED ·Phase: NA
-
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
NCT00002184 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
NCT00001045 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
NCT00002014 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
NCT00004852 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir
NCT00002423 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
NCT00002426 ·Status: COMPLETED ·Phase: NA